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RESEARCH ARTICLE
Functional and radiological outcomes of atypical femur fractures among elderly
in Karachi, Pakistan
Rizwan Haroon Rashid, Marij Zahid, Usama Khan, Yasir Mohib, Pervaiz Hashmi

Abstract
Objective: To assess the functional and radiological outcomes in a unique class of fractures i.e. atypical femur
fractures and to assess the effects of osteoblastic agents in healing.
Methods: It is a retrospective observational study conducted at Aga Khan University Hospital, Karachi, Pakistan. All
patients with atypical femur fractures who were surgically managed with intramedullary nailing from January, 2013
to June, 2017 and with a follow-up till December 2019, were included in the study. Radiological outcomes were
expressed as mean healing time and functional outcomes were recorded as mean Short Musculoskeletal Functional
Assessment (SMFA) score.
Results: A total of twenty-four patients were included in this study. Mean age of patients was 65.8 ± 8 years. Mean
healing time was 10 ±3.2 months post operatively. Two patients underwent redo procedures. No other
complications like paresthesia or weakness was observed in any patients. All the patients reported a good score on
SMFA ranging from 19% to 31%.
Conclusion: Intra-medullary nailing shows a promising result in treatment of atypical femur fractures. Use of postoperative osteoblastic supplements showed statistically significant results with early healing time (p=0.008 [95%
CI]).
Keywords: Osteoporosis; Atypical femur fractures, Strontium, Teriperatide, Pathological fractures.
(JPMA 71: S-13 [Suppl. 5]; 2021)

Introduction
Over 200 million people suffer from osteoporosis
worldwide and is considered as a major health concern.1
Osteoporosis is considered to be the 2nd most critical
health problem by the World Health Organization. In
Pakistan the prevalence of osteoporosis is suggested to
be 9.1 million and it is further estimated that this figure
was projected to rise by 11.3 million by the year 2020
overburdening an already resource constrained
environment.2 These figures suggest a major burden of
osteoporosis in health sector of Pakistan.
Bisphosphonates have been the first line therapy for
management of osteoporosis for the past 20 years.3,4 They
reduce osteoclastic bone resorption and the net result is a
rapid and substantial decrease in bone turnover markers
resulting in a modest increase in bone mineral density
(BMD).5 It has been proposed that severe and prolonged
suppression of bone turnover may impair the ability of
bone re-modelling leading to an accumulation of micro
damage and reduction of bone strength5-7 resulting in
iatrogenic fractures.
Atypical femoral fractures (AFFs) are defined as
Department of Orthopedic Surgery, Aga Khan University Hospital, Karachi,
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atraumatic or low-energy trauma fractures located in the
sub-trochanteric region or femoral shaft.8 Patients usually
present with a history of prodromal pain in the affected
thigh, months prior to the actual injury which should
prompt a physician to ask specifically for bisphosphonate
use and then correlate with the radiology. Radiological
features of AFFs are unique and include a simple
transverse pattern with a uni-cortical break in an area of
cortical hypertrophy.7 The diagnosis of AFFs specifically
excludes femoral neck fracture, high impact trauma
related fractures, pathological fractures associated with
primary or secondary tumours, intertrochanteric
fractures, and peri-prosthetic fractures.9 American Society
for Bone and Mineral Research (ASBMR) has devised
criteria for diagnosing an atypical fracture with major and
minor features.10 Few drugs like bisphosphonates,
glucocorticoids, proton- pump inhibitors and medical
conditions such as diabetes, rheumatoid arthritis and
vitamin D deficiency are included in the minor criteria.10
Understanding the scarce literature and need for
evaluation of these fractures this study was carried out for
better understanding of the outcomes of surgically
managed AFFs.

Materials and Methods
This study was a retrospective observational study
conducted at Aga Khan University Hospital, Karachi,
Vol. 71, No. 8 (Suppl. 5), August 2021
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Pakistan after the institutional ethics review committee
approval (ERC# 4759-Sur-ERC-17). Patients who were
diagnosed for AFFs according to the ASBMR criteria10 and
surgically managed with intra medullary nail between
January, 2013 to June, 2017 were included in this study
and data was analyzed after final follow-ups of all patients
in December 2019. Sample size was calculated via WHO
sample size calculator tool estimating population
proportion of 0.9811 with absolute precision required of
0.06, the sample size required for the study was 21
patients. We included 24 patients in our study. Patient's
demographic data including age, gender, occupation,
duration of previous bisphosphonate use, mechanism of
injury, fracture site of femur either sub-trochanteric or
femur shaft, duration of surgery and post-operative use of
bone remodeling agents were collected from the
patients' charts and recorded on a preformed structured
proforma. Serial radiographs were viewed to ascertain the
fracture healing and consolidation on regular follow-ups.
Patients were followed for a minimum period of 24
months post operatively. Short Musculoskeletal
Functional Assessment (SMFA) score12 was calculated via
telephonic interview after verbal consent and used to
assess the functional outcome of patients with a lesser
score indicating better outcome. Categorical variables
were recorded as frequency and percentages and chisquare test or Fischer exact test was applied for analysis.
Continuous variables were expressed as means with
standard deviation, Data was checked for normality via
Shapiro-Wilk test and student t-test was applied to
compare means for analysis. A p-value of less than 0.05
was considered significant for inferential analysis.
Statistical package for the social sciences (SPSS) version
20 was used for all analysis.

Results
A total of 24 patients were included in this study of whom
21 were females and 3 were males. Mean age of the
patients was 65.5±8 years. Majority of the patients
sustained ground level fall. Twenty (83.3%) fractures
occurred in sub-trochanteric region while 4 (16.7%) were
femoral shaft fractures. Five patients out of 24 (20.8%) had
a history of steroid use. Twenty-two patients took
bisphosphonates for osteoporosis while 2 patients had
never used them. Mean duration for bisphosphonates
usage was 6.4±1.3 years. None of the patients took any
other medication for osteoporosis prior to the fracture. Six
patients reported a history of prodromal thigh pain with a
mean duration of 1.6± 0.7 months (Table-1).
All the patients were surgically managed with
intramedullary nailing device (Figure-1 & 2). Mean
duration of hospital stay was 6.75 ±2.3 days. Mean time
J Pak Med Assoc (Suppl. 5)

Table-1: Patient demographics and fracture characteristics.
Variable

Mean/Count (%)

Mean Age (years)
Gender
Male
Female
Steroid Use
Yes
No
Mechanism of Injury
Ground level fall
Non traumatic
Prodromal Pain
Yes
No
Fracture location
Sub-trochanteric
Femur shaft

65.5±8.0
3 (12.5%)
21 (87.5%)
5 (20.8%)
19 (79.2%)
22 (91.6%)
2 (8.3%)
6 (25%)
18 (75%)
20 (83.3%)
4 (16.6%)

Table-2: Stratified healing times according to osteoblastic agents.

Healing time
(months)

Use of Supplement

Mean (months)

Yes (n=17)
No (n=7)
Strontium (n=11)
Teriparatide (n=6)

7.24±2.0
12.71± 3.3
7.36 ± 2.1
7.00 ± 2.0

Significance

0.08
0.73

for fracture healing was 10.8 ± 3.2 months. Five (20.83%)
patients had dynamization of nail 3 months after index
surgery. Two (8.3%) patients underwent additional
procedures at 5th and 7th month respectively due to
delayed union and were subjected to bone grafting. Both
patients healed after 4 months of second surgery. All the
patients reported a good score on SMFA with mean
26.29% ± 2.89 (range 19% to 31%). Mean follow up time
was recorded as 26.4±2.75 months (Range 24-35). All the
patients stopped using bisphosphonate after surgery.
Interestingly accelerated fracture healing was associated
with use of osteoblastic agents like Strontium Ranelate
and Teriperatide which was given to the patients as per
surgeons' discretion. Patients who used any osteoblastic
supplements post operatively showed a better mean
healing time of 7.2 ± 2 months while mean healing time
of 12.7 ± 3.3 months was observed in those patients who
were not prescribed any agent (p=0.008). Eleven patients
were prescribed Strontium Ranelate as per treating
surgeons' discretion while 6 used Teriparatide as
osteoblastic agents. Patients using Strontium had a mean
healing time of 7.36±2.1 months while for Teriparatide
group it was 7.0±2 months. Comparison of Strontium and
Teriparatide using patients and mean healing time was
not found to be statistically significant (Table-2).
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The association between long-term bisphosphonate use
and unusual diaphyseal fractures was first described in
2005 by Odvina et al.13 Many studies have documented
this association14 while according to Rizzoli et al, this case
is yet unproven.15 For the past 2 decades,
bisphosphonates have been the main stay treatment for
the prevention of osteoporosis related fractures. In year
2005, it was reported that prolonged use of BP has
association with an unusual diaphyseal fracture and later
it was termed as atypical femoral fracture by ASBMR.16
The first report from the ASBMR task force published in
2010 showed lack of studies regarding management and
outcomes for atypical femoral fractures.10

Figure-1: (a & b) X-ray's pelvis AP and femur AP views of a 68 year old lady with trivial
injury showing left sided sub-trochanteric fracture with oblique pattern. (c & d)
Postoperative radiographs at 6 months follow up showing intra-medullary nail in situ
and good healing at post-op 6 months.

Figure-2: (a & b) 72 year old lady 8 years on bisphosphonates had a low energy ground
level fall , radiographs show left sided sub-trochanteric fracture with oblique pattern
and medial beak with cortical thickening pathognomic of atypical fracture. (c & d) Postoperative radiographs at 6 month follow up showing intra-medullary nail in situ and
good healing at post-op 6 months 21.

Discussion
Atypical femurs are not uncommon but still are tricky to
pick and require prompt careful history taking and
assessment. The mechanism of action and fracture
pattern on radiographs are the key to correct diagnosis.
Our study delineates various aspects of assessment
including specific questions while taking history such as
prodromal pain, bisphosphonates use and its duration.

Egol et al. had reported a good outcome of surgically
managed atypical femoral fractures with 98% of fractures
healing at 12 months, and 60% becoming pain free postoperatively11 whereas in our study, mean healing time
was 10 months. Ha et al. studied the necessity of surgical
management for atypical femoral fractures and their
study population reported a 100% healing rate after
surgical fixation17 which is comparable to our study.
A case series of 21 patients of atypical femoral fractures
showed a positive relation with smoking and steroid use
while all the fractures were managed with intra medullary
nailing and only one had non-union and rest healed
uneventfully.18 In our study none of the selected patients
had history of smoking and 5 patients used steroids.
There was no significant relationship found for the usage
of steroids or cigarette smoking.
Ekstrom et al reported 25% mortality at 2 year follow-up
in patients managed surgically for atypical femoral
fractures, while 52% did not achieve the pre-fracture
quality of life.19 There were no reported mortality of
subjects in our study. In our data the SMFA scores were
reported to be good in patients with early healing time.
High scores were encountered in patients with delayed
union or who underwent additional procedures. Weil et.al
conducted a study which showed much higher failure
rates with intra medullary nailing for atypical femoral
fractures and requiring revision surgery, 54% achieved
fracture healing while 46% had to undergo a revision
surgery.20 Subramanian et.al reported a good surgical
outcome for atypical femoral fractures with all the
patients having uneventful healing while only one
fracture developed non-union requiring revision
surgery.18 Our study results showed that only two
patients had to undergo redo surgery due to non-union
after initial management but later achieved union.
There were no studies found to have comparison
between usage of post-operative supplements like
Vol. 71, No. 8 (Suppl. 5), August 2021
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Teriperatide and Strontium. In our study we found an
association between early fracture healing with use of
osteoblastic drugs warranting better SMFA as compared
to those who did not use it. Since this was an observation,
further studies are required to look in this association
more closely.

6.

7.

The strengths of the study is its adequate follow up period
to delineate union and occurrence of any re-fracture.
Moreover it provides an association between use of
osteoblastic agents and healing time. The limitations of
our study were a small sample size, its retrospective
nature, and the functional outcome assessed over a
telephonic interview.

8.

Conclusion

11.

This study reported comparatively good outcome for
patients with atypical femoral fractures when managed
with intra-medullary nailing. Use of post-operative
osteoblastic supplements showed statistically significant
results with early healing time, hence warranting further
prospective studies and randomized controlled trials to
study the relationship and association of Teriparatide or
Strontium Ranelate with healing after surgical
management.
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